In silico identification of potential dynamin-related protein 1 antagonists: Implications for diseases involving mitochondrial dysfunction

Combinatorial Chemistry and High Throughput Screening

Volumn 17, Issue 1, 2014, Pages 25-34

  Hanumanthappa, Pradeep ^a   Rajanikant, Golgodu K ^a  

^a NATIONAL INSTITUTE OF TECHNOLOGY CALICUT   (India)

Author keywords

Dynamin related protein 1; Homology modeling; Mitochondrial fission; Molecular docking; Molecular dynamics; Virtual screening

Indexed keywords

DYNAMIN I; DYNAMIN RELATED PROTEIN 1 ANTAGONIST; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; COMPUTER MODEL; CRYSTAL STRUCTURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; DRUG PROTEIN BINDING; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PHARMACOPHORE; PRIORITY JOURNAL;

BINDING SITES; CARDIOVASCULAR DISEASES; CRYSTALLOGRAPHY, X-RAY; DATABASES, CHEMICAL; DRUG DISCOVERY; ENZYME INHIBITORS; GENE EXPRESSION; GTP PHOSPHOHYDROLASES; HOMEOSTASIS; HUMANS; LIGANDS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; NEURODEGENERATIVE DISEASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN; USER-COMPUTER INTERFACE;

EID: 84893332127     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/1386207311316010044     Document Type: Article

References (44)

1. Nakamura, T.; Cieplak, P.; Cho, D.H.; Godzik, A.; Lipton, S.A. Snitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration. Mitochondrion, 2010, 10, 573-578.
2. Ong, S.B.; Subrayan, S.; Lim, S.Y.; Yellon, D.M.; Davidson, S.M; Hausenloy, D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation, 2010, 121, 2012-2022.
3. Lee, Y.; Lee, H.Y.; Hanna, R.A.; Gustafsson, A.B. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol., 2011, 301, H1924-H1931.
4. Men, X.; Wang, H.; Li, M.; Cai, H.; Xu, S.; Zhang, W.; Xu, Y.; Ye, L.; Yang, W.; Wollheim, C.B.; Lou, J. Dynamin-related protein 1 mediates high glucose induced pancreatic beta cell apoptosis. Int. J. Biochem. Cell Biol., 2000, 41, 879-890.
5. Rolland, S.; Conradt, B. The role of mitochondria in apoptosis induction in Caenorhabditis elegans: more than just innocent bystanders? Cell Death Differ., 2006, 13, 1281-1286.
6. Cereghetti, G.M.; Costa, V.; Scorrano, L. Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin. Cell Death Differ., 2010, 17, 1785-1794.
7. Frank, S.; Gaume, B.; Bergmann-Leitner, E.S.; Leitner, W.W.; Robert, E.G.; Catez, F.; Smith, C.L.; Youle, R.J. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell, 2001, 1, 515-525.
8. Ferrari, L.F.; Chum, A.; Bogen, O.; Reichling, D.B.; Levine, J.D. Role of Drp1, a key mitochondrial fission protein, in neuropathic pain. J. Neurosci., 2011, 31, 11404-11410.
9. Makino, A.; Scott, B.T.; Dillmann, W.H. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia, 2010, 53, 1783-1794.
10. Park, S.W.; Kim, K.Y.; Lindsey, J.D.; Dai, Y.; Heo, H.; Nguyen, D.H.; Ellisman, M.H.; Weinreb, R.N.; Ju, W.K. A selective inhibitor of drp1, mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina. Invest. Ophthalmol. Vis. Sci., 2011, 512, 2837-2843.
11. Frecer, V. Theoretical prediction of drug-receptor interactions. Drug Metabol. Drug Interact., 2011, 26, 91-104.
12. Dror, R.O.; Dirks, R.M.; Grossman, J.P.; Xu, H.; Shaw, D.E. Biomolecular simulation: a computational microscope for molecular biology. Annu. Rev. Biophys., 2012, 41, 429-452.
13. Davis, I.W.; Murray, L.W.; Richardson, J.S.; Richardson, D.C. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res., 2004, 32, W615-W619.
14. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst., 1993, 26, 283-291.
15. Teli, M.K.; Rajanikant, G.K. Pharmacophore generation and atombased 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors. J. Enzyme Inhib. Med. Chem., 2012, 27, 558-570.
16. Halgren, T.A.; Murphy, R.B.; Friesner, R.A.; Beard, H.S.; Frye, L.L.; Pollard, W.T.; Banks, J.L. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem., 2004, 47, 1750-1759.
17. Loving, K.; Salam, N.K.; Sherman, W. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation. J. Comput. Aided Mol. Des., 2009, 23, 541-554.
18. Pradeep, H.; Rajanikant, G.K. A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β. Mol. Divers., 2012, 16, 553-562.
19. Tewatia, P.; Malik, B.K.; Sahi, S. Identification of novel β3-adrenoceptor agonists using energetic analysis, structure based pharmacophores and virtual screening. Comb. Chem. High Throughput Screen., 2012, 15, 623-640.
20. Dixon, S.L.; Smondyrev, A.M.; Rao, S.N. PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem. Biol. Drug Des., 2006, 67, 370-372.
21. Teli, M.K.; Pradeep, H.; Rajanikant, G.K. Pharmacophore generation and 3D-QSAR of novel 2-(quinazolin-4-ylamino)-[1,4] benzoquinone derivatives as VEGFR-2 inhibitors. Lett. Drug Des. Discov., 2012, 9, 899-914.
22. Teli, M.K.; Krishnamurthy, R.G. Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors. Org. Med. Chem. Lett., 2012, 2, 25-35.
23. Teli, M.K.; Krishnamurthy, R.G. Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening. Mol. Divers, 2012, 16, 193-202.
24. Badrinarayan, P.; Sastry, G.N. Virtual high throughput screening in new lead identification. Comb. Chem. High. Throughput Screen., 2011, 14, 840-860.
25. Koes, D.R.; Camacho, C.J. Pharmer: Efficient and Exact Pharmacophore Search. J. Chem. Inf. Model, 2011, 51, 1307-1314.
26. Irwin, J.J.; Shoichet, B.K. ZINC-a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model, 2005, 45, 177-182.
27. Nair, S.B., Fayaz, S.M. Krishnamurthy, R.G. In silico prediction of novel inhibitors of the DNA binding activity of FoxG1. Med. Chem., 2012, 8, 1155-1162.
28. Teli, M.K.; Krishnamurthy, R.G. A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors. Med. Chem., 2012, 8.
29. Nair, S.B.; Teli, M.K.; Pradeep, H.; Rajanikant, G.K. Computational identification of novel histone deacetylase inhibitors by docking based QSAR. Comput. Biol. Med., 2012, 42, 697-705.
30. Hanumanthappa, P.; Teli, M.K.; Krishnamurthy, R.G. Generation of pharmacophore and atom based 3D-QSAR model of novel isoquinolin-1-one and quinazolin-4-one-type inhibitors of TNFa. Med. Chem., 2012, 8, 436-451.
31. Agrawal, R.; Jain, P.; Dikshit, S.N. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents. Comb. Chem. High. Throughput Screen., 2012, 15, 849-876.
32. Nikolic, K.; Veljkovic, N.; Gemovic, B.; Srdic-Rajic, T.; Agbaba, D. Imidazoline-1 Receptor Ligands as apoptotic agents: Pharmacophore Modeling and Virtual Docking study. Comb. Chem. High. Throughput Screen., 2013, 16 (4), 298-319.
33. Subramaniam, S.; Mehrotra, M.; Gupta, D. Support vector machine based prediction of P. falciparum proteasome inhibitors and development of focused library by molecular docking. Comb. Chem. High. Throughput Screen., 2011, 14, 898-907.
34. Plewczynski, D.; von Grotthuss, M.; Rychlewski, L.; Ginalski, K. Virtual high throughput screening using combined random forest and flexible docking. Comb. Chem. High. Throughput Screen., 2009, 12, 484-489.
35. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shaw, D. E.; Shelley, M.; Perry, J. K.; Francis, P.; Shenkin, P. S. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem., 2004, 47, 1739-1749.
36. Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory Comput., 2008, 4, 435-447.
37. Zoete, V.; Cuendet, M.A.; Grosdidier, A.; Michielin, O. SwissParam: a fast force field generation tool for small organic molecules. J. Comput. Chem., 2011, 32, 2359-2368.
38. Bjelkmar, P.; Larsson, P.; Cuendet, M.A.; Hess, B.; Lindahl, E. Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models. J. Chem. Theory Comput., 2010, 6, 459-466.
39. Sborgi, L.; Verma, A.; Munoz, V.; de Alba, E. Revisiting the NMR structure of the ultrafast downhill folding protein gpW from bacteriophage ?. PLoS One. 2011, 6, e26409-e26417.
40. Yogurtcum O.N.; Erdemli, S.B.; Nussinov, R.; Turkay, M.; Keskin, O. Restricted mobility of conserved residues in protein-protein interfaces in molecular simulations. Biophys J., 2008, 94, 3475-3485.
41. Bhattacharya, N.; Ghosh, S.; Sept, D.; Cooper, J.A. Binding of myotrophin/V-1 to actin-capping protein: implications for how capping protein binds to the filament barbed end. J. Biol. Chem., 2006, 281, 31021-31030.
42. Darden, T.; York, D.; Pedersen, L. Particle mesh ewald-an N. log(N) method for ewald sums in large systems. J. Chem. Phys., 1993, 98, 10089-10093.
43. Berendsen, H.J.C.; Postma, J.P.M.; Van Gunsteren, W.F.; DiNola, A.; Haak, J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys., 1984, 81, 3684-3691.
44. Humphrey, W.; Dalke, A.; Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph., 1996, 14, 33-38.